Ultima Genomics, Exact Sciences In Deal To Improve Patient Access To Genomics-based Testing

(RTTNews) – Ultima Genomics, Inc. and Exact Sciences Corporation (EXAS) have inked a long-term supply deal through which Exact Sciences will receive Ultima’s next-generation sequencing or NGS technologies to reduce the high cost of sequencing and to support patient access to geno

This post was originally published on this site